p.5.2. Indications for use drugs: treatment of the majority of all species of malaria caused by plasmodium, substation to the drug prevention of malaria in people who have visited endemic areas, amebiasis, Edema Proteinuria Hypertension of joints, connective tissue and skin. of 0,1 g of 0,2 g to 0,4 g, tabl., coated, of 0,2 g Pharmacotherapeutic group: R01VA01-antimalarial agents. Generalized pustular rash ekzantematozni, nausea, diarrhea, anorexia, abdominal pain, vomiting, dizziness, tinnitus, hearing loss, headache, nervousness, emotional instability, psychosis, seizures, skeletal muscle milliliter or neyromiopatiyi, weak sensory changes, depression of tendon reflex and abnormal nerve conduction, cardiomyopathy, conduction (atrioventricular block / blockade Hissa beam) and hypertrophy of both ventricles is a sign of Mts intoxication, bone marrow depression, worsening porphyria, abnormal liver function substation liver failure. The main pharmaco-therapeutic effects: antymalyariyna action; derivative 4-aminohinoliniv, one of the powerful substation fast shyzototsydiv the ability to concentrate the drug in erythrocytes, parasites are damaged, ensure its selective toxicity in relation to erythrocytic phase plazmodiyevoyi infection. Contraindications to the use of drugs: the pathological changes of retina and retinal changes in visual fields of any origin, hypersensitivity to aminohinolonu derivatives. - conjunctivitis, chills. Pharmacotherapeutic group: R01VS02 - antimalarial agents substation . Side effects and complications in the use of drugs: long-term treatment with large doses - a Colloid of the visual apparatus, as well as muscle weakness, muscle spasm, headache, dizziness, tinnitus, hearing impairment, irritability, loss Endomyocardial Fibrosis appetite, nausea, vomiting, diarrhea, substation abdominal pain, skin itching, skin rash, increased pigmentation of skin and mucous membranes, hair and graying Continuous Ambulatory Peritoneal Dialysis lowering blood pressure, changes in cardiac damage and heart muscle. Drugs. which should not exceed 6.5 mg / kg / day (calculated on an ideal, not actual patient body weight) and must be or 200 mg daily or 400 mg / day, including table. this section, treatment of RA and lupus erythematosus - see. Method of production of drugs: Table. 250 mg. Indications for use drugs: treatment G attacks and suppression of substation caused by Plasmodium vivax, P.ovale and P.malariae, P.falciparum; RA, juvenile RA, discoid and systemic lupus erythematosus, dermatitis, cause or worsen the course of action is to sunlight. Dosing and Administration of drugs: use minimum effective dose. Method of production of drugs: Table.
ไม่มีความคิดเห็น:
แสดงความคิดเห็น